Introduction
Globally, migraine is a common disease, with about 1.3 billion people suffering from them; female patients are 3–4 times more common than male patients [
1]. It is the second-highest specific cause of disability worldwide [
2]. Depression, anxiety and insomnia often occur in migraine sufferers, especially in those who have chronic migraine [
3,
4]. In general, pain is positively correlated with accompanying symptoms. Migraine poses a significant psychological, healthy and financial burden to sufferers. There are many factors that can trigger migraines, with common triggers including stress, disrupted sleep, emotional agitation, menstruation, noise, light, hot and cold weather and fatigue [
5‐
7].
Anxiety is widely believed to increase the burden of migraines. A large prospective study with more than 5000 participants found that anxiety intensity was associated with headaches in individuals with tension-type headaches, migraine and coexisting tension-type headaches and migraine [
8]. Migraine predicts depression, while depression also predicts migraine in subjects, a link that is partly mediated by anxiety [
9]. In fact, mood disorders and migraines can interact and induce bipolar disorder (BD) in severe cases. Evidence suggests that depression often precedes migraines [
10], while previous studies have shown that migraine sufferers have a high incidence of BD; a family history of BD is a risk factor for migraine deterioration [
11]. In addition, insomnia is the most common sleep disorder among patients with migraine, in a relationship that appears bidirectional [
12]. Evidence supports the suggestion that migraine sufferers have worse sleep quality than non-migraine sufferers [
13]. Boardman and colleagues published longitudinal data showing that insomnia preceded and predicted new onset headache and the exacerbation of migraine [
14,
15]. Conversely, migraine headaches are also a precursor to insomnia [
16].
The main goals of the acute treatment of migraine include rapidly treating the attack with minimal recurrence, reducing the use of additional rescue medications, restoring function, minimizing subsequent resource use, being cost-effective and minimizing the occurrence of adverse events [
17,
18]. However, it is often overlooked how important mood disorders and mental health are to the recovery and daily life of migraine sufferers. At present, the pathogenesis of migraine is not yet clear. Scholars consider it to be mostly related to neurovascular factors among others. Drug treatment is commonly used in clinical practice, such as non-steroidal anti-inflammatory drugs (NSAIDs), barbiturates and opioids, but the efficacy is not good and adverse reactions often occur [
19], and there are no specific medications to improve mental health throughout the course of illness. Acupuncture treatment for this disease has a long history; it is safe and effective and has been widely recognized in clinical practice [
20]. The latest clinical guidelines of Western medicine also recommend acupuncture for the prevention and treatment of migraine [
21,
22]. Compared with medication, acupuncture therapy is more cost-effective and has fewer side effects, making it an attractive option for the auxiliary regulation and prevention of various chronic diseases [
23]. The goals of acupuncture treatment are usually two-fold: to relieve pain during a migraine attack and to prevent future migraine attacks [
24,
25]. In addition, acupuncture can effectively relieve migraine, adjust the mental and psychological state of patients and improve the depression/anxiety disorder of migraine patients [
26,
27]. Acupuncture was also supported by relevant studies in improving other concomitant symptoms and quality of life of migraine patients. For example, regulating social functions, role emotions and improving the quality of life all have certain promoting effects [
28‐
31].
Although there is evidence that acupuncture can prevent and relieve migraine and concomitant symptoms such as depression and sleep disturbances, several long-term follow-ups of high-quality RCTs indicate that acupuncture improves the frequency of migraine attacks and the length of the headache, but do not specify whether the long-term follow-up after treatment could improve the mental health of patients [
20,
28,
30‐
32]; therefore, the long-term effectiveness of acupuncture in improving mental health in migraine patients is unclear. In order to better understand the effectiveness of acupuncture for migraine and its impact on patients’ quality of life and related mental health, including pain and mood disorders, we conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) of acupuncture for migraine.
Method
The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [
33] and complied with the PRISMA check list. It was approved by the International Prospective Register of Systematic Reviews (PROSPERO) on February 5, 2022, with the registration number: CRD42022300712.
Search strategy
PubMed, Cochrane Library, Embase, Web of Science, Chinese National Knowledge Infrastructure (CNKI) and Wan Fang Data Knowledge Service Platform were visited to identify randomized controlled trials of acupuncture in the treatment of migraine; the supplementary literature was manually searched. Search terms were as follows: “headache”, “migraine”, “cephalgia”, “cephalalgia”, “acupuncture”, “manual acupuncture”, “electro-acupuncture”, “auricular acupuncture”, “migraine and acupuncture”. All search dates were completed by December 31, 2021, we included RCTs published before January 1, 2021.
Types of study selected
The studies were RCTs or controlled clinical trials on acupuncture for migraine, with or without blinding or allocation concealment. The following articles were excluded: (1) case reports, reviews and animal studies, (2) repeated experiments, (3) no clear diagnostic criteria for migraine, irregular patient assessment and (4) During the treatment, the experimental group used a treatment other than acupuncture (such as acupuncture combined with traditional Chinese medicine or moxibustion).
Types of patients included
Patients were diagnosed as “migraine” under the internationally recognized diagnostic criteria for migraine, regardless of age, sex, course and case origin; no other diseases were included.
Types of intervention included
The experimental group was treated with acupuncture, including traditional acupuncture, electro-acupuncture, ear acupuncture, warm acupuncture, etc. while the control group was treated with sham acupuncture or drugs. The details of the acupuncture method are clearly explained, including the selection of needles, acupoints, operations and treatment processes, according to the Intervention Standards for Acupuncture Clinical Experiment Reports [
34].
Types of outcomes
Since the purpose of this study was to investigate the effects of acupuncture on anxiety, depression and other emotional disorders in migraine patients, the main outcome indicators such as Pain-Related Mood Disorders (Zung Self-Rated Anxiety Scale (SAS), Zung Self-rating Depression Scale (SDS) and Short Form 36 Mental Health (MH) that can better reflect the improvement of mood were selected as the main outcome indicators. Although we focused more on mood disorders associated with migraines, pain and quality of life scores in migraine patients were also of concern, so we chose Visual Analog Scale (VAS) scores for acupuncture migraine and Migraine-Specific Quality of Life Questionnaire (MSQ) emotional Functioning Subscaleas secondary outcomes.
Two independent reviewers performed data extraction. Extracted data included study design, diagnostic criteria, migraine duration, sample size, age, gender of participants, intervention, control, duration of treatment, duration of follow-up and adverse events. Incomplete data or inquiries were followed up with the original authors by phone and email.
Risk of bias
We assessed the risk of bias in the included literature using Cochrane RoB2.0 [
35]. Each randomized controlled trial was evaluated according to the following six items:(1) the randomization process; (2) Interventions that deviate from expectations; (3) Lack of result data; (4) Measurement results; (5) Select report results; (6) Overall. If the methodology used is appropriate and properly and clearly described, the study is considered low risk; Otherwise, if the method cannot be accurately judged, it is rated as high risk, or there are some problems. Two investigators independently assessed these factors and, if necessary, consulted a third investigator (SY) to resolve differences.
Statistical analysis
Two researchers performed statistical analysis of the data using Stata 16.0 software. Dichotomous variables are shown as risk ratios (RR) and corresponding 95% CIs. Continuous data were expressed as weighted mean differences (WMD) or standardized mean differences (SMD) and corresponding 95% CI values, with reference to I2 and P values to determine whether there was heterogeneity in the assessment statistics. If I2 > 50% or P < 0.01, indicating significant heterogeneity, a random effects model was employed, otherwise, a fixed effects model was used. If there was significant heterogeneity, subgroup analysis or meta-regression was performed to discover sources of heterogeneity. In the statistical description, P < 0.05 was considered statistically significant. In addition, a sensitivity analysis was performed to test the soundness of the results by excluding low-quality trials. Funnel and Egger plots were used to detect publication bias and when significant publication bias was found, a trim-fill method was used to test the stability of the results.
Discussion
This study aimed to evaluate the efficacy of acupuncture in improving the mental health of migraine patients. We found that the experimental group and the control group had statistical significance in improving SAS, SDS MH, VAS and MSQ in migraine patients.
The pathogenesis of migraine is not fully understood and its pathogenesis involves complex pathophysiological changes [
44]. Migraine attacks can be accompanied by a variety of neurological, gastrointestinal and autonomic changes [
45] and should not be considered a vascular headache alone [
46]. Some scholars have proposed that migraine is triggered by activation of the trigeminal sensory pathway [
47]. The basis of the characteristic symptoms of migraine may be related to auditory, visual and olfactory cortical areas receiving trigeminal sensory input, while somatosensory, insular, retrosplenic and parietal relevant cortical areas are closely related to sensory discrimination, emotional and cognitive evaluation of trigeminal nociceptive input [
48]. Interictal calcitonin gene-related peptide (CGRP) and vasoactive intestinal peptide (VIP) levels in patients with chronic migraine were higher than those in patients with episodic migraine [
49], suggesting that the interictal activities of the trigeminal nerve and cranial autonomic nervous system changed in patients with chronic migraine.
Chronic migraine is not life-threatening, but can seriously affect the patient’s quality of life. Studies have shown that migraine patients are more likely to suffer from anxiety and depression than healthy people [
50] and the risk of disability is greatly increased. Current first-line drugs for migraine include divalproex, topiramate, metoprolol, propranolol and timolol [
51]. However, in the prophylactic treatment of migraine and its associated symptoms, the administration of a single drug to treat both conditions may not be effective and optimal [
52], so a combination of drugs is often required and taken over a long period of time. As a supplementary therapy for migraine, acupuncture is well tolerated and has few adverse reactions, so it is widely used in clinical practice [
53]. Numerous studies have also confirmed that acupuncture is an effective method for the treatment of migraine [
54].
Regarding the mechanism of acupuncture in the treatment of migraine, some scholars have conducted animal experiments and studies have shown that electroacupuncture significantly improves mechanical and thermal hyperalgesia, reduces c-Fos levels in trigeminal ganglia and decreased levels of vasoactive neurotransmitters in plasma and dura mater [
55]. Electroacupuncture can improve migraine and related cutaneous hypersensitivity reactions by modulating the ascending pathway of the trigeminal vasculature, partly by inhibiting the expression of CGRP in the trigeminal ganglion [
42] and by increasing the receptors in the periorbital region of the trigeminal nerve. Other studies have shown that electroacupuncture inhibits hyperalgesia induced by dural electrical stimulation (DES) by reducing inflammatory factors. The inhibition of dural mast cells, macrophages and serum inflammatory factors may be one of the mechanisms of acupuncture in the treatment of migraine [
56]. There are also clinical studies showing that acupuncture can significantly reduce matrix metalloproteinase-2 (MMP-2) in migraine patients [
57]. Therefore, it is speculated that the mechanism of acupuncture to relieve pain may be related to the reduction of MMP-2. In addition, acupuncture can relieve headache by modulating the neural activity of related brain regions by regulating the frontal, parietal and limbic regions of the brain for specific therapeutic effects and non-specific analgesics [
58].
The interventions tested in the RCTs in 13 studies were all acupuncture and we did not differentiate between acupoint selection and manipulation, which may have contributed to heterogeneity. In a broad sense, electro-acupuncture, warm acupuncture, ear acupuncture and body acupuncture belong to acupuncture and moxibustion, but the related literature on ear acupuncture, electro-acupuncture and other treatments were excluded because they were inconsistent with the purpose of this study. Studies on acupoint injection and acupoint pressing were excluded because acupoint pressing belongs to massage, while acupoint injection is often conducted with drugs and does not belong to the scope of acupuncture and moxibustion. The control group received sham acupuncture or drugs. The drug group used different drugs, including flunarizine, valproic acid, tanasedone and topiramate. However, because the sample size of the included literature is small and the doses of different drugs are inconsistent, the main observation indicators in this paper focus is on the psycho-emotional effects of acupuncture in patients with migraine. It is well known that sham acupuncture and drugs are treated in significantly different ways, so we conducted a subgroup analysis of different interventions in the control group. This may be the main reason for the significant heterogeneity of results.
There are some limitations to our study: first, there was large heterogeneity between analyses. This may be related to the inconsistency of acupoint selection, treatment time and follow-up time; the difference in sample size may also be one of the important factors affecting the results. There are studies showing that the differences in the effects of various acupuncture experiments are mainly driven by the differences in the treatments received by the control group, rather than differences in the characteristics of acupuncture treatments [
59]. Secondly, it is extremely difficult to reach a complete double-blind experiment. The blindness caused by fake acupuncture and drugs will be suspected by patients, because of the different intervention measures, whether compared with drugs or sham acupuncture, patients easily sense the differences in acupuncture experiments. We believe that the main reason for this is related to patient self-assessment. As the measurement indicators and scores in the results are subjective feelings of the patients, the expected treatment effect and results are different from the experimental results, which may lead to different scores. In addition, patients’ trust in acupuncturists and different techniques of acupuncturists also contribute to the differences in results. After all, a comfortable acupuncture experience is more acceptable to each patient. Moreover, the acupuncture treatment time, ranging from 1 to 12 weeks, and the follow-up time, ranging from 8 to 24 weeks, in the literature are relatively large. Which is more likely to be accepted by doctors or patients is rarely mentioned. Finally, there is no clear generation of random sequences or allocation concealment, resulting in high publication bias.
Therefore, to address potential limitations, we believe that a large-sample, multicenter clinical randomized controlled trial is important and a more rigorous RCT is necessary. Some suggestions include: (1) the definition of long-term and short-term effects should be clarified in acupuncture experiments; (2) the selection of acupoints could be more standardized; (3) appropriate addition and subtraction based on the dialectics of traditional Chinese medicine can more effectively avoid heterogeneity, to improve the comparability of acupuncture and moxibustion with drugs or other treatments and the feasibility of research.
The results of this study show that acupuncture has advantages in treating migraine and improving our quality of life and mental health, so we believe that acupuncture can be a recommended treatment modality. Moreover, the frequency of adverse events of acupuncture is lower and the most common ones are local pain and blood stasis [
60], which can disappear naturally after acupuncture stops. Therefore, we recommend acupuncture for migraine.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.